medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 11

<< Back Next >>

Ginecol Obstet Mex 2022; 90 (11)

Castleman Disease. Case report and literature review

Iturralde-Rosas PP, Gómezpedroso-Rea J, Mancera-Reséndiz MÁ, Stuht-López D, Ubiergo-García M, Cabrera-Zavala A
Full text How to cite this article

Language: Spanish
References: 7
Page: 910-915
PDF size: 387.20 Kb.


Key words:

Castleman disease, Angiofollicular lymph node hyperplasia, Viral infections, Young adult, Herpesvirus 8, Human, Immunohistochemistry.

ABSTRACT

Background: Castleman's disease, or angiofollicular lymph node hyperplasia, is a diagnostic and therapeutic challenge for most physicians. It may be associated with viral infections, such as herpes virus type 8, or be idiopathic. In turn, it can be localized in a single region (unicentric) or affect several (multicentric). It is usually diagnosed in the fourth decade of life and is a finding when it is the unicentric variant.
Clinical case:19 year old patient who came to consult due to the appearance of a nodule in the right breast. Breast and axillary ultrasound showed bilateral fibroadenomas and adenomegaly on the left side, with high vascularity. It was classified as BIRADS 3. The histopathological report of the biopsy, with cutting needle, of the left axillary node was: atypical lymphoid proliferation. Immunohistochemistry reported positivity for: CD20, CD3, CD21 on interfollicular dendritic cells, Ki-67 and negativity for HHV-8 in residual germinal centers.
Conclusion: Surgical removal of a unicentric hyaline-vascular-plasmic type mass is curative. Evaluation of patients with suspected disease should include, in addition to pathologic evaluation with immunostaining, laboratory and systemic imaging studies with PET-CT to determine the extent of disease (unicentric or multicentric) and for follow-up markers.


REFERENCES

  1. Dispenzieri A, Fajgenbaum DC. Overview of Castlemandisease. Blood 2020; 135 (16): 1353-64. doi: 10.1182/blood.2019000931

  2. Abramson JS. Diagnosis and management of CastlemanDisease. J Natl Compr Canc Netw 2019; 17 (115): 1417-19.doi: 10.6004/jnccn.2019.5037

  3. Wang W, Medeiros LJ. Castleman Disease. Surg Pathol Clin2019; 12 (3): 849-63. doi: 10.1016/j.path.2019.03.003

  4. Dispenzieri A. POEMS Syndrome: 2019 Update on diagnosis,risk-stratification, and management. Am J Hematol2019; 94 (7): 812-27. doi: 10.1002/ajh.25495

  5. Vasilyev VI, Palshina SG, Pavlovskaya AI, Kokosadze NV,Chaltsev BD, Shornikova LA. Idiopathic multicentricCastleman's disease. Ter Arkh 2020; 92 (5): 78-84. doi: 10.26442/00403660.2020.05.000440

  6. Van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, LimM, Dispenzieri A, et al. International evidence-based consensusdiagnostic and treatment guidelines for unicentricCastleman disease. Blood Adv 2020; 4 (23): 6039-50. doi:10.1182/bloodadvances.2020003334

  7. Carbone A, Borok M, Damania B, Gloghini A, PolizzottoMN, Jayanthan RK, Fajgenbaum DC, Bower M. Castlemandisease. Nat Rev Dis Primers 2021; 7 (1): 84. doi: 10.1038/s41572-021-00317-7




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2022;90